Aurora Private Wealth, Inc. Amgen Inc Transaction History

Aurora Private Wealth, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$255.7 - $288.46 $219,646 - $247,787	859 New	859 $247,000
Q2 2022 Jul 21, 2022	BUY	$230.71 - $256.74 $2.63 Million - $2.93 Million	11,418 New	11,418 $55,000
Q4 2020 Jan 15, 2021	SELL	$216.38 - $257.67 $206,210 - $245,559	-953 Closed	0 $0
Q3 2020 Oct 26, 2020	SELL	$234.65 - $260.95 $81,423 - $90,549	-347 Reduced 26.69%	953 $242,000
Q2 2020 Jul 27, 2020	SELL	$197.81 - $242.74 $72,596 - $89,085	-367 Reduced 22.02%	1,300 $307,000
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $61,050 - $80,969	335 Added 25.15%	1,667 $338,000
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $252,027 - $323,942	1,332 New	1,332 $321,000

3,144

415M

8.2M

6.65M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $156B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Aurora Private Wealth, Inc., based on Form 13F filings with the SEC.

Stay updated on Aurora Private Wealth, Inc. with notifications on news.